Skip to content

ddI treatment sole risk factor for noncirrhotic portal hypertension

Nevirapine matches atazanavir/ritonavir in 48-week study

Hepatitis C co-infection increases risk of many AIDS-defining illnesses

Genotypic tests matches tropism test in predicting who benefits from CCR5 inhibitors

Hepatitis B vaccine scale-up and treatment of HIV/HBV co-infection present challenges

Increased risk of HIV transmission in serodiscordant couples wishing to conceive

Raltegravir moves closer to approval for first-line use in Europe

Malaria cases fall with each year of HIV treatment in Ugandan patients

Older patients on ART in West Africa have higher risk of death